USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements…
1D
+1.0%
1W
+6.0%
1M
+5.6%
6M
-22.5%
YTD
-20.8%
1Y
-26.2%
2Y
-57.6%
5Y
-84.3%
10Y
-78.9%
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~74% stronger price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$35.00
CONSENSUS
US$35.00
MEDIAN
US$35.00
PRICE TARGET HIGH
US$35.00
0
STRONG BUY
2
BUY
5
HOLD
1
SELL
0
STRONG SELL
8
TOTAL · Hold
As of: 27/02/2025
P/E
-12.87
P/B
0.55
EV/EBITDA
2.84
RETURN ON EQUITY
-4.1%
NET MARGIN
-9.6%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
04/07/2026
FREE FLOAT
53.7%
FLOAT SHARES
9,928,920
AVG. DAILY VOLUME (30D)
190,773
FULLER GILBERT A
WOOD TIMOTHY E
WOOD TIMOTHY E
Winssinger Frederic J
Nixon J Scott
USANA Health Sciences, Inc. is a company in the Consumer Defensive sector, Packaged Foods industry, headquartered in United States.
The CEO is Kevin G. Guest, the company employs around 1,570 people.
The IPO was on 04/04/1994; the stock trades on NYSE under the ticker USNA.
8 analysts rate the stock, the consensus is Hold (as of 27/02/2025).
The average price target is US$35.00, ranging from US$35.00 to US$35.00, with a median of US$35.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 74% stronger than usual.
No, USANA Health Sciences currently does not pay a dividend.
Comparable stocks include Kraft Heinz Company, General Mills, J. M. Smucker Company, McCormick & Company, Hormel Foods, Darling Ingredients, Central Garden & Pet Company and Utz Brands.
Clicking "Analyze stock" lets five strategies assess USANA Health Sciences against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.